Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment in 2025
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > The Dawg's stock analysis
View:
Post by DJDawg on Nov 30, 2022 2:08pm

The Dawg's stock analysis

My personal, non-expert stock movement commentary
  • I know that many were hoping for a nice price bump because of the quarterly update, however
  • At this time there is a limited pool of people who know about TLT. That pool has not had much reason to get bigger because there is no PR effort.
  • As such the pool is made up of:
    • TLT longholders who never sell
    • TLT longholders who have bought max that they can buy
    • TLT nervous followers who have bought some and would buy more given the right dramatic signal (sorry, yesterday’s release isn’t quite dramatic enough)
    • TLT swing traders who have made small chunks of money selling a bit higher and then walking the price down to buy more at a lower price.
  • The one other category would be TLT holders who are so suddenly excited that they rush to sell other stocks they hold to use the money for more TLT. These people are not jumping with a bigger purchase unless the news is BTD, AA…
 
Given that there is no PR, the most recent news can only influence the above pool of traders. But what can they do with the news? The first aren’t selling so not a huge volume on the ask (for 200+ m shares out there). The second are maxed out so can only watch. The third are not confident enough yet. The people who might sell other stocks in a rush to buy more TLT have not got the BTD signal yet. This leaves the share price entirely dependent on the swing traders and the nervous traders who jump out quite easily for not much reason.
 
Going forward the issues above will mean that the stock will trade low volumes, and probably walk in random directions here and there. If it is a walk down then that is fairly typical and is due to the swingers and the nervous traders. Unless there is PR to get new people to notice, there just are not any new buyers yet.
 
Big catalysts to come (the only way to change what is above)
  • JV announcement would be great.
  • RDW takes over and calls up every news outlet and starts a big PR push.
  • BTD announcement (I’m pretty sure that few companies announce that they have APPLIED from my internet search. They announce when they get it for sure)
  • IND application for GBM/SCLC leading to a new angle for a PR push and JV search.
  • (Vaccine development…not seeing that as being a big thing for now. )
 
Please point out if I’m wrong in the analysis. I appreciate the good discussion.
Comment by Legit62 on Nov 30, 2022 2:39pm
DJDawg, right on, best analysis so far, now we wait
Comment by Donein25 on Nov 30, 2022 2:45pm
Nice analysis Dawg. Agree on BTD and RDW catalysts, then maybe a JV around any AA. A few folks were looking for vaccine news in Q4 but it seems the update there now suggests a long drawn out process. Now developing TLC-3000B and then 1 year animal testing.
Comment by StevenBirch on Nov 30, 2022 3:24pm
Dawg I like your analysis except for one thing - PR. I don't think it has anything to do with PR as we see before the market opens and before some can even digest the news release someone throws in over 200K on the sell side. I don't know who it is but I would bet every last share I have that they are a buyer, a large buyer. They have said they will be applying for BTD soon, if they don& ...more  
Comment by Infinity on Nov 30, 2022 7:03pm
Nice one Dawg.  I agree, we need to be more vocal about the achievements. The best thing that can happen would be to hire a PR company.  Once the stock prices gets into the $3 range which is very likely when BTD and or AA is announced.  Uplist to TSX and Nasdaq.  This stock needs more institutional investors.  Most of them are restricted and cannot invest penny stock for ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed in 2025, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250